Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (1543)	9/1/2000 12:50:58 PM
From: Biomaven	Respond to of 52153

Scott, universe of SNP companies This issue is certainly worth looking at, especially as they seem to be breeding like rabbits. There are at least two angles here - the "pick and shovel" companies, and those trying to somehow make a buck by collating, analyzing or using SNP's in drug development or diagnostics. Here's a quick list in no discernable order, courtesy 10K-Wizard (I might have missed a couple): ORCH SQNM GNSC GMNI VGNX ILMN INCY ACLA PEB LJLB TWTI NGEN SGMO NGEN AFFX GENE LYNX GNOM STGN GENXY BDAL RSTA NENL MDCC EPPHZ LMNX DCGN INMX GLGC CALP GNMX And of course there's the pharma-funded consortium in the mix as well. For some of these SNP's are just a small part of what they do, but it's a place to start. Peter P.S. To keep on with the theme, Orchid is the one which is the MLNM partner on SNP scoring <g>